131 related articles for article (PubMed ID: 11850116)
1. Age-related phenotypes in the staggerer mouse expand the RORalpha nuclear receptor's role beyond the cerebellum.
Jarvis CI; Staels B; Brugg B; Lemaigre-Dubreuil Y; Tedgui A; Mariani J
Mol Cell Endocrinol; 2002 Jan; 186(1):1-5. PubMed ID: 11850116
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of Purkinje cells in two RORalpha gene mutant mice: staggerer and RORalpha(-/-).
Doulazmi M; Frédéric F; Capone F; Becker-André M; Delhaye-Bouchaud N; Mariani J
Brain Res Dev Brain Res; 2001 Apr; 127(2):165-74. PubMed ID: 11335003
[TBL] [Abstract][Full Text] [Related]
3. staggerer phenotype in retinoid-related orphan receptor alpha-deficient mice.
Steinmayr M; André E; Conquet F; Rondi-Reig L; Delhaye-Bouchaud N; Auclair N; Daniel H; Crépel F; Mariani J; Sotelo C; Becker-André M
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3960-5. PubMed ID: 9520475
[TBL] [Abstract][Full Text] [Related]
4. Enhanced endocrine response to novel environment stress and lack of corticosterone circadian rhythm in staggerer (Rora sg/sg) mutant mice.
Frédéric F; Chianale C; Oliver C; Mariani J
J Neurosci Res; 2006 Jun; 83(8):1525-32. PubMed ID: 16555296
[TBL] [Abstract][Full Text] [Related]
5. The "CholesteROR" protective pathway in the vascular system.
Boukhtouche F; Mariani J; Tedgui A
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):637-43. PubMed ID: 14751813
[TBL] [Abstract][Full Text] [Related]
6. Orphan nuclear receptor ROR alpha-deficient mice display the cerebellar defects of staggerer.
Dussault I; Fawcett D; Matthyssen A; Bader JA; Giguère V
Mech Dev; 1998 Jan; 70(1-2):147-53. PubMed ID: 9510031
[TBL] [Abstract][Full Text] [Related]
7. Alteration of cerebellar neurotropin messenger ribonucleic acids and the lack of thyroid hormone receptor augmentation by staggerer-type retinoic acid receptor-related orphan receptor-alpha mutation.
Qiu CH; Shimokawa N; Iwasaki T; Parhar IS; Koibuchi N
Endocrinology; 2007 Apr; 148(4):1745-53. PubMed ID: 17218417
[TBL] [Abstract][Full Text] [Related]
8. Smooth muscle dysfunction in resistance arteries of the staggerer mouse, a mutant of the nuclear receptor RORalpha.
Besnard S; Bakouche J; Lemaigre-Dubreuil Y; Mariani J; Tedgui A; Henrion D
Circ Res; 2002 Apr; 90(7):820-5. PubMed ID: 11964376
[TBL] [Abstract][Full Text] [Related]
9. Purkinje cell fate in staggerer mutants: agenesis versus cell death.
Vogel MW; Sinclair M; Qiu D; Fan H
J Neurobiol; 2000 Feb; 42(3):323-37. PubMed ID: 10645972
[TBL] [Abstract][Full Text] [Related]
10. RORalpha, a pivotal nuclear receptor for Purkinje neuron survival and differentiation: from development to ageing.
Boukhtouche F; Doulazmi M; Frederic F; Dusart I; Brugg B; Mariani J
Cerebellum; 2006; 5(2):97-104. PubMed ID: 16818384
[TBL] [Abstract][Full Text] [Related]
11. Cerebellar purkinje cell loss in heterozygous rora+/- mice: a longitudinal study.
Doulazmi M; Capone F; Frederic F; Bakouche J; Lemaigre-Dubreuil Y; Mariani J
J Neurogenet; 2006; 20(1-2):1-17. PubMed ID: 16807193
[TBL] [Abstract][Full Text] [Related]
12. The gene encoding fibrinogen-beta is a target for retinoic acid receptor-related orphan receptor alpha.
Chauvet C; Bois-Joyeux B; Fontaine C; Gervois P; Bernard MA; Staels B; Danan JL
Mol Endocrinol; 2005 Oct; 19(10):2517-26. PubMed ID: 15941850
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the nuclear hormone receptor RORalpha in staggerer mice.
Hamilton BA; Frankel WN; Kerrebrock AW; Hawkins TL; FitzHugh W; Kusumi K; Russell LB; Mueller KL; van Berkel V; Birren BW; Kruglyak L; Lander ES
Nature; 1996 Feb; 379(6567):736-9. PubMed ID: 8602221
[TBL] [Abstract][Full Text] [Related]
14. The structural integrity of ROR alpha isoforms is mutated in staggerer mice: cerebellar coexpression of ROR alpha1 and ROR alpha4.
Matysiak-Scholze U; Nehls M
Genomics; 1997 Jul; 43(1):78-84. PubMed ID: 9226375
[TBL] [Abstract][Full Text] [Related]
15. Enhanced susceptibility of staggerer (RORalphasg/sg) mice to lipopolysaccharide-induced lung inflammation.
Stapleton CM; Jaradat M; Dixon D; Kang HS; Kim SC; Liao G; Carey MA; Cristiano J; Moorman MP; Jetten AM
Am J Physiol Lung Cell Mol Physiol; 2005 Jul; 289(1):L144-52. PubMed ID: 15778248
[TBL] [Abstract][Full Text] [Related]
16. Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha.
Mamontova A; Séguret-Macé S; Esposito B; Chaniale C; Bouly M; Delhaye-Bouchaud N; Luc G; Staels B; Duverger N; Mariani J; Tedgui A
Circulation; 1998 Dec; 98(24):2738-43. PubMed ID: 9851961
[TBL] [Abstract][Full Text] [Related]
17. A promoter element with enhancer properties, and the orphan nuclear receptor RORalpha, are required for Purkinje cell-specific expression of a Gi/o modulator.
Serinagaoglu Y; Zhang R; Zhang Y; Zhang L; Hartt G; Young AP; Oberdick J
Mol Cell Neurosci; 2007 Mar; 34(3):324-42. PubMed ID: 17215137
[TBL] [Abstract][Full Text] [Related]
18. Cytological compartmentalization in the staggerer cerebellum, as revealed by calbindin immunohistochemistry for Purkinje cells.
Nakagawa S; Watanabe M; Isobe T; Kondo H; Inoue Y
J Comp Neurol; 1998 May; 395(1):112-20. PubMed ID: 9590549
[TBL] [Abstract][Full Text] [Related]
19. ROR alpha in genetic control of cerebellum development: 50 staggering years.
Gold DA; Gent PM; Hamilton BA
Brain Res; 2007 Apr; 1140():19-25. PubMed ID: 16427031
[TBL] [Abstract][Full Text] [Related]
20. Increased ischemia-induced angiogenesis in the staggerer mouse, a mutant of the nuclear receptor Roralpha.
Besnard S; Silvestre JS; Duriez M; Bakouche J; Lemaigre-Dubreuil Y; Mariani J; Levy BI; Tedgui A
Circ Res; 2001 Dec; 89(12):1209-15. PubMed ID: 11739287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
